These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30369082)

  • 21. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
    Zhang Z; Xu X; Tian W; Jiang R; Lu Y; Sun Q; Fu R; He Q; Wang J; Liu Y; Yu H; Sun B
    J Hepatol; 2020 May; 72(5):976-989. PubMed ID: 31857195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
    Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes.
    Zhu X; Gan-Schreier H; Otto AC; Cheng Y; Staffer S; Tuma-Kellner S; Ganzha A; Liebisch G; Chamulitrat W
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):677-687. PubMed ID: 30735854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.
    Zhang X; Shen J; Man K; Chu ES; Yau TO; Sung JC; Go MY; Deng J; Lu L; Wong VW; Sung JJ; Farrell G; Yu J
    J Hepatol; 2014 Dec; 61(6):1365-75. PubMed ID: 25048951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8
    Muñoz-Durango N; Arrese M; Hernández A; Jara E; Kalergis AM; Cabrera D
    Front Immunol; 2020; 11():563434. PubMed ID: 33391254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
    J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G
    Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M; Csak T; Szabo G
    World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theabrownin ameliorates liver inflammation, oxidative stress, and fibrosis in MCD diet-fed C57BL/6J mice.
    Zhen Q; Liang Q; Wang H; Zheng Y; Lu Z; Bian C; Zhao X; Guo X
    Front Endocrinol (Lausanne); 2023; 14():1118925. PubMed ID: 36742397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
    Galastri S; Zamara E; Milani S; Novo E; Provenzano A; Delogu W; Vizzutti F; Sutti S; Locatelli I; Navari N; Vivoli E; Caligiuri A; Pinzani M; Albano E; Parola M; Marra F
    Clin Sci (Lond); 2012 Oct; 123(7):459-71. PubMed ID: 22545719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.
    Ji G; Wang Y; Deng Y; Li X; Jiang Z
    Lipids Health Dis; 2015 Oct; 14():134. PubMed ID: 26498332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL/6J mouse.
    Gautam J; Aggarwal H; Kumari D; Gupta SK; Kumar Y; Dikshit M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Dec; 1869(8):159545. PubMed ID: 39089643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.